Literature DB >> 20030562

Human-induced pluripotent stem cells produced under xeno-free conditions.

Pablo Juan Ross1, Steven Thomas Suhr, Ramon Maria Rodriguez, Eun-Ah Chang, Kai Wang, Kannika Siripattarapravat, Tak Ko, Jose Bernardo Cibelli.   

Abstract

Induced pluripotent stem cells (iPSCs) have radically advanced the field of regenerative medicine by making possible the production of patient-specific pluripotent stem cells from adult individuals. While cell differentiation protocols have been successfully developed, and animal models of human disease have proved that these cells have the potential to treat human diseases and conditions produced as a consequence of aging, degeneration, injury, and birth defects, logistical issues still remain unsolved and hamper the possibility of testing these cells in human clinical trials. Among them is the widely spread use of animal products for the generation and culture of iPSCs. We report here a xeno-free iPSC generation system that addresses all the steps of iPSCs production including the isolation and culture of adult skin fibroblasts, and iPSCs generation, expansion, and maintenance. iPSCs generated with a polycistronic lentiviral vector under xeno-free conditions displayed markers of pluripotency and gave rise to embryoid bodies (EBs) displaying indicators of the 3 primary germ layers. Xeno-free iPSCs injected into nude mice produced classic teratomas, and teratoma explants cultured under conditions favoring fibroblastic cells gave rise to cells morphologically indistinguishable from input cells. Protocols here described will facilitate the implementation of new cellular therapies for preclinical and clinical studies, potentially reducing the regulatory burden without compromising the differentiation potential of the cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20030562     DOI: 10.1089/scd.2009.0459

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  17 in total

1.  Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.

Authors:  Silke Wissing; Martin Muñoz-Lopez; Angela Macia; Zhiyuan Yang; Mauricio Montano; William Collins; Jose Luis Garcia-Perez; John V Moran; Warner C Greene
Journal:  Hum Mol Genet       Date:  2011-10-11       Impact factor: 6.150

2.  Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

Authors:  Veronica Ramos-Mejia; Gustavo J Melen; Laura Sanchez; Ivan Gutierrez-Aranda; Gertrudis Ligero; Jose L Cortes; Pedro J Real; Clara Bueno; Pablo Menendez
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

3.  Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.

Authors:  Wentao Hu; Yongpei He; Yongjie Xiong; Hong Lu; Hong Chen; Limin Hou; Zhandong Qiu; Yu Fang; Suming Zhang
Journal:  Mol Neurobiol       Date:  2015-02-10       Impact factor: 5.590

4.  Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells.

Authors:  Jiesi Luo; Steven T Suhr; Eun Ah Chang; Kai Wang; Pablo J Ross; Laura L Nelson; Patrick J Venta; Jason G Knott; Jose B Cibelli
Journal:  Stem Cells Dev       Date:  2011-06-15       Impact factor: 3.272

Review 5.  Cell replacement therapies: is it time to reprogram?

Authors:  Harald M Mikkers; Christian Freund; Christine L Mummery; Rob C Hoeben
Journal:  Hum Gene Ther       Date:  2014-09-17       Impact factor: 5.695

6.  Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.

Authors:  Francisco dos Santos; Pedro Z Andrade; Manuel M Abecasis; Jeffrey M Gimble; Lucas G Chase; Andrew M Campbell; Shayne Boucher; Mohan C Vemuri; Cláudia Lobato da Silva; Joaquim M S Cabral
Journal:  Tissue Eng Part C Methods       Date:  2011-09-06       Impact factor: 3.056

7.  Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.

Authors:  Yohei Hayashi; Techuan Chan; Masaki Warashina; Masakazu Fukuda; Takashi Ariizumi; Koji Okabayashi; Naoya Takayama; Makoto Otsu; Koji Eto; Miho Kusuda Furue; Tatsuo Michiue; Kiyoshi Ohnuma; Hiromitsu Nakauchi; Makoto Asashima
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

8.  Lead exposure disrupts global DNA methylation in human embryonic stem cells and alters their neuronal differentiation.

Authors:  Marie-Claude Senut; Arko Sen; Pablo Cingolani; Asra Shaik; Susan J Land; Douglas M Ruden
Journal:  Toxicol Sci       Date:  2014-02-11       Impact factor: 4.849

Review 9.  A decade of transcription factor-mediated reprogramming to pluripotency.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444

10.  From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols.

Authors:  Saravanan Karumbayaram; Peiyee Lee; Soheila F Azghadi; Aaron R Cooper; Michaela Patterson; Donald B Kohn; April Pyle; Amander Clark; James Byrne; Jerome A Zack; Kathrin Plath; William E Lowry
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.